A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life, mindfulness-related capacities, and a decrement of psychopathological symptoms M. V. Uthaug, R. Lancelotta, K. van Oorsouw, K. P. C. Kuypers, N. Mason, J. Rak, A. Šuláková, R. Jurok, M. Maryška, M. Kuchař, T. Páleníček, J. Riba, J. G. Ramaekers Psychopharmacology, 2019 https://doi.org/10.1007/s00213-019-05236-w Abstract Background : 5-methoxy-N,N-dimethyltryptamine (hereinafter referred to as 5-MeO-DMT) is a psychedelic substance found in the secretion from the parotoid glands of the Bufo alvarius toad. Inhalation of vapor from toad secretion containing 5-MeO-DMT has become popular in [...]
Lire la suitePsilocybin and Mental Health–Don’t Lose Control (Opinion) Joseph M. Barnby and Mitul A. Mehta Frontiers in Psychiatry, published: 03 July 2018 | Volume 9 | Article 293 doi: 10.3389/fpsyt.2018.00293 Keywords : psychedelics, psilocybin, depression, clinical trials, methodology Psilocybin—the hallucinogenic pro-drug in magic mushrooms—has recently dominated the popular narrative on new approaches to treating depression. For example, recent papers from John’s Hopkins (1) and Imperial College (2, 3) demonstrate the potential for psilocybin to promote positive lifestyle changes, and as an intervention for treatment-resistant depression, respectively. They also provide an opportunity to highlight two recurrent issues with psychedelic research which we place in the context of more [...]
Lire la suiteAyahuasca and the Healing of Eating Disorders Marika Renelli, Jenna Fletcher, Anja Loizaga-Velder, Natasha Files, Kenneth Tupper and Adele Lafrance Jul 2018 Chapter in "Embodiment and Eating Disorders" Eating disorders (EDs) are complex mental health issues that involve cognitive, physical and emotional symptoms (Golden et al., 2003; Polivy & Herman, 2002). It is widely accepted that the avoidance of challenging emotions is central to the development and maintenance of an ED (Harrison, Sullivan, Tchanturia, & Treasure, 2009). Many have theorized that an individual’s focus on and negative view of body image, along with attempts to change their body are more strongly related to the embodiment [...]
Lire la suiteLSD Brings Your Brain to the Edge of Chaos This new LSD study is like an acid trip all on its own. This story was first published by Tonic, VICE's health site. You can now find the same great health content right here at vice.com. One Saturday in 1964, neurologist Oliver Sacks took a bit of amphetamines, LSD, a “touch” of cannabis, faced a white wall in his home, and said “I want to see indigo now—now!” “And then,” he wrote in the New Yorker in 2012, “as if thrown by a giant paintbrush, there appeared a huge, trembling, pear-shaped blob of the [...]
Lire la suiteLSD Changes Something About The Way You Perceive Time We measure time in set amounts— seconds, minutes, and hours. But the way time feels is more slippery. Shayla Love, December 3, 2018, Grotmarsel/ Getty This story was first published by Tonic, VICE's health site. You can now find the same great health content right here at vice.com. In 2015, when cognitive neuroscientist Devin Terhune was hit by a car, the impact took less than a second, but he felt it to be much longer. “I was riding [my bike] very fast, and so when I hit the car I went flying back around 15 feet or more,” he [...]
Lire la suitePsychedelic therapy as a complementary treatment approach for alcohol use disorders Peter EISCHENS and William Leigh ATHERTON Journal of Psychedelic Studies, 2018, 2, (1), pp. 36–44 DOI: 10.1556/2054.2018.005 Background : Traditional treatment interventions for alcohol use disorders (AUD) have produced mixed outcomes and the global increase in AUDs demands novel and innovative approaches to addiction treatment. Psychedelic substances have been reintroduced into the Western medical community as a potential intervention to complement the treatment of AUDs. Objectives : This paper will discuss the implications of using psychedelic substances as a complementary approach within the treatment of AUDs. Methods : A thorough review of pertinent research focused [...]
Lire la suiteThe Ethics of Taking the Drugs You Study Should psychedelic scientists trip on the drugs they research? Shayla LOVE VICE.com, May 14 2019 From 1960 to 1962, the Harvard Psilocybin Project conducted unconventional experiments, like giving psilocybin to prison inmates to see if it would reduce recidivism, or doling it out to theology students to provoke a religious experience. Led by Timothy Leary and Richard Alpert, their goal was to test the potential applications of the active ingredient in magic mushrooms. Leary was a clinical psychologist and professor at Harvard. After taking mushrooms in 1960, he “declared that he learned more in the following five [...]
Lire la suiteMental health of a self-selected sample of psychedelic users and self-medication practices with psychedelics Natasha L. MASON and Kim P. C. KUYPERS Journal of Psychedelic Studies, 2018, 2, (1), pp. 45–52 DOI: 10.1556/2054.2018.006 Background : A substantial number of people worldwide suffer from mental health problems during their lifetime. First-line treatments are not effective for everybody. Recent studies suggest that psychedelic drugs have high therapeutic potential for a variety of mental disorders. Aims : This survey study aimed to assess the tendency of psychedelic users to self-medicate with psychedelics and to compare the effectiveness of self-administered psychedelics to treat their disorder and the treatment offered [...]
Lire la suitePerceptions of the medicinal value of hallucinogenic drugs among college students JARED I. WILDBERGER, CASSANDRA N. JOHN and ROBERT M. HALLOCK Journal of Psychedelic Studies, 2017, 1(2), pp. 50–54 DOI: 10.1556/2054.01.2017.008 Background : This survey examined perceptions among college students about the potential medicinal benefits of hallucinogenic drugs. Current research and potential benefits include an ability to help anxiety, post-traumatic stress disorder, and addiction with hallucinogen-assisted psychotherapy. Methods : We devised and administered a survey on 124 students at two college campuses, one small private college in the mid-Atlantic and one medium-sized public university in the Midwest of the United States. Results: Responses were similar [...]
Lire la suiteTreating drug dependence with the aid of ibogaine: A qualitative study EDUARDO EKMAN SCHENBERG, MARIA ANGÉLICA DE CASTRO COMIS, JOÃO FELIPE MOREL ALEXANDRE, BRUNO DANIEL RASMUSSEN CHAVES, LUÍS FERNANDO TO´ FOLI and DARTIU XAVIER DA SILVEIRA Journal of Psychedelic Studies, 2017, 1, (1), pp. 10–19 DOI: 10.1556/2054.01.2016.002 Background : Substance use disorders are important contributors to the global burden of disease, but current treatments are not associated with high rates of recovery. The lack of approved and effective treatments is acutely problematic for psychostimulants like cocaine and crack cocaine. One promising alternative in the treatment of drug dependence in general and psychostimulants in particular [...]
Lire la suite